Here are four points:
1. Profit Investment Management’s holdings in NuVasive were worth $1.17 million as of its most recent SEC filing.
2. NuVasive has a 12-month low of $36.81 and a 12-month high of $56.61.
3. The stock has a 50-day moving average price of $47.04 and a 200-day moving average price of $50.56.
4. The stock has a market cap of $1.96 billion.
More articles on devices:
FDA to require PMAs for 2 types of metal-on-metal hip replacement devices — 5 takeaways
ACL reconstruction gets virtual reality makeover — 5 insights
HCA, SpineGuard pen national contract — 5 highlights
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
